Elizabeth L. Kramer, MD, PhD
- Assistant Professor, UC Department of Pediatrics
- elizabeth.kramer@cchmc.org
- Board Certified
About
Biography
I love working with children — they are resilient, funny and brave. It's my goal to help children breathe well so they can live the life they want.
As a pediatric pulmonologist, I specialize in taking care of children with lung disease, including those with asthma, chronic cough, recurrent pneumonia and cystic fibrosis. I am a member of the Cystic Fibrosis Center at Cincinnati Children’s.
I work with children and their families to form personalized care plans. Parents are the experts on their own child, and I want to help them take care of their child's lungs.
In my research, I am interested in why cystic fibrosis lung disease severity is so variable from person to person. I am studying a chemical made in the body, called TGFbeta, which might worsen lung disease in certain people. Studying this chemical may help us discover new therapies to stop early lung damage in cystic fibrosis.
I am a recipient of the Procter Scholar Award, which supports highly promising junior faculty pursuing a career in academic research. My research has been supported by funding from the Cystic Fibrosis Foundation and Cystic Fibrosis Research, Inc.
When I’m not at work, I enjoy spending time with my husband and two daughters. We have lived in Cincinnati more than 15 years.
PhD: University of Cincinnati, Cincinnati, OH, 2009.
MD: University of Cincinnati, Cincinnati, OH, 2011.
Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2014.
Fellowship: Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2016.
Certification: Pediatrics, 2014.
Services and Specialties
Pulmonary Medicine, Cystic Fibrosis Center
Research Areas
Pulmonary Medicine
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Heterogeneity in Neutrophil Extracellular Traps from Healthy Human Subjects. International Journal of Molecular Sciences. 2024; 25.
CFTR dysfunction in smooth muscle drives TGFβ dependent airway hyperreactivity. Respiratory Research. 2023; 24:198.
Heterogeneity in Neutrophil Extracellular Traps from Healthy Human Subjects. 2023.
168 Impact of TGF-β exposure on IL-6 secretion in cystic fibrosis airway epithelia. Journal of Cystic Fibrosis. 2023; 22:s89.
98 Neutrophil extracellular traps disrupt bronchial epithelial junctional integrity and promote infection. Journal of Cystic Fibrosis. 2023; 22:s51.
Alpha-1 antitrypsin limits neutrophil extracellular trap disruption of airway epithelial barrier function. Frontiers in Immunology. 2023; 13:1023553.
27 Effect of SARS-CoV-2 on long-term physical and mental health symptoms in people with cystic fibrosis and their caregivers. Journal of Cystic Fibrosis. 2022; 21:s16-s17.
380 Neutrophil extracellular traps disrupt bronchial epithelial barrier function: Alpha-1 antitrypsin to the rescue. Journal of Cystic Fibrosis. 2022; 21:s223.
Sensitive structural and functional measurements and 1-year pulmonary outcomes in pediatric cystic fibrosis. Journal of Cystic Fibrosis. 2021; 20:533-539.
Data driven decision making to characterize clinical personas of parents of children with cystic fibrosis: a mixed methods study. BMC Pulmonary Medicine. 2020; 20:174.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey